Boston, MA, United States of America

Theodore R Mellors

USPTO Granted Patents = 4 

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
4 patents (USPTO):

Title: The Innovations of Theodore R Mellors

Introduction

Theodore R Mellors is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune disorders. With a total of 4 patents, his work focuses on utilizing machine learning classifiers to enhance treatment efficacy for patients suffering from rheumatoid arthritis.

Latest Patents

Mellors' latest patents include innovative methods for treating subjects suffering from rheumatoid arthritis with anti-TNF therapy. These methods are based in part on a trained machine learning classifier. The systems and methods he presents are designed to develop classifiers that predict patient responses to specific treatments. In some embodiments, his disclosure provides a method of treating subjects with an autoimmune disorder by administering alternatives to anti-TNF therapy. This is particularly aimed at subjects who have been determined to be non-responsive to traditional anti-TNF therapy, utilizing a classifier established to distinguish between responsive and non-responsive patients.

Career Highlights

Theodore R Mellors is currently associated with Scipher Medicine Corporation, where he continues to innovate in the medical field. His work is pivotal in advancing treatment methodologies that leverage technology to improve patient outcomes.

Collaborations

Mellors collaborates with notable colleagues such as Marc Santolini and Asher Ameli, contributing to a dynamic team focused on medical advancements.

Conclusion

Theodore R Mellors exemplifies the spirit of innovation in the medical field, utilizing technology to enhance treatment options for patients with autoimmune disorders. His contributions are paving the way for more effective therapies and improved patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…